KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Short term Debt: 2009-2022

Historic Short term Debt for Clorox (CLX) over the last 5 years, with Mar 2022 value amounting to $600.0 million.

  • Clorox's Short term Debt rose 100.00% to $600.0 million in Q1 2022 from the same period last year, while for Mar 2022 it was $600.0 million, marking a year-over-year increase of 100.00%. This contributed to the annual value of $300.0 million for FY2021, which is N/A change from last year.
  • Per Clorox's latest filing, its Short term Debt stood at $600.0 million for Q1 2022, which was down 0.00% from $600.0 million recorded in Q4 2021.
  • In the past 5 years, Clorox's Short term Debt registered a high of $899.0 million during Q3 2021, and its lowest value of $300.0 million during Q4 2020.
  • For the 3-year period, Clorox's Short term Debt averaged around $519.6 million, with its median value being $600.0 million (2022).
  • Examining YoY changes over the last 5 years, Clorox's Short term Debt showed a top increase of 100.00% in 2021 and a maximum decrease of 52.98% in 2021.
  • Over the past 4 years, Clorox's Short term Debt (Quarterly) stood at $396.0 million in 2019, then reached $300.0 million in 2020, then spiked by 100.00% to $600.0 million in 2021, then soared by 100.00% to $600.0 million in 2022.
  • Its Short term Debt stands at $600.0 million for Q1 2022, versus $600.0 million for Q4 2021 and $899.0 million for Q3 2021.